Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
4basebio PLC · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $35.00M | $35.00M - $35.00M | -$35.00M | -$0.30 | 1 |
| Dec 2028 | $25.00M | $25.00M - $25.00M | -$25.00M | -$0.50 | 1 |
| Dec 2027 | $15.00M | $15.00M - $15.00M | -$15.00M | -$0.78 | 1 |
| Dec 2026 | $2.60M | $2.60M - $2.60M | -$2.60M | -$1.00 | 1 |
| Dec 2025 | $1.70M | $1.70M - $1.70M | -$1.70M | -$1.10 | 1 |
| Dec 2024 | $1.10M | $700.0K - $1.50M | -$1.10M | -$0.871 | 2 |
| Dec 2023 | $596.0K | $596.0K - $596.0K | -$596.0K | -$0.786 | 1 |
| Dec 2022 | $300.0K | $293.2K - $306.8K | -$284.9K | -$0.411 | 1 |
| Dec 2021 | $300.0K | $293.2K - $306.8K | -$284.9K | -$0.269 | 1 |
| Dec 2020 | $400.0K | $390.9K - $409.1K | -$379.9K | -$0.118 | 1 |